Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study
The amygdala is a prominent region of the brain that plays a critical role in the pathophysiology of major depressive disorder (MDD). The amygdala is formed from a collection of interconnected substructures (nuclei) that relay signals from multiple brain areas, which suggests that the amygdala has d...
Saved in:
Main Authors: | Naomichi Okamoto (Author), Keita Watanabe (Author), Hirofumi Tesen (Author), Atsuko Ikenouchi (Author), Ryohei Igata (Author), Yuki Konishi (Author), Tomoya Natsuyama (Author), Rintaro Fujii (Author), Shingo Kakeda (Author), Taro Kishi (Author), Nakao Iwata (Author), Reiji Yoshimura (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression
by: Reiji Yoshimura, et al.
Published: (2021) -
Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
by: Reiji Yoshimura, et al.
Published: (2022) -
Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary study
by: Naomichi Okamoto, et al.
Published: (2021) -
Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan
by: Taro Kishi, et al.
Published: (2020) -
Corrigendum: Estimation of subjective quality of life in schizophrenic patients using speech features
by: Yuko Shibata, et al.
Published: (2023)